These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3240774)
1. The hypoglycemic effects of tryptamine in mice: mediation by 5-HT receptors. Yamada J; Sugimoto Y; Kimura I; Takeuchi N; Horisaka K Eur J Pharmacol; 1988 Nov; 156(2):299-301. PubMed ID: 3240774 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of tryptamine on tolbutamide-induced hypoglycemia in mice: mediation by 5-HT receptors. Sugimoto Y; Yamada J; Kimura I; Watanabe Y; Horisaka K Neurochem Res; 1994 Jan; 19(1):19-22. PubMed ID: 8139757 [TBL] [Abstract][Full Text] [Related]
3. Serotonin-induced hypoglycemia and increased serum insulin levels in mice. Yamada J; Sugimoto Y; Kimura I; Takeuchi N; Horisaka K Life Sci; 1989; 45(20):1931-6. PubMed ID: 2689822 [TBL] [Abstract][Full Text] [Related]
4. The activation of serotonin receptors by tryptamine induces hyperinsulinemia in mice. Yamada J; Sugimoto Y; Kimura I; Takeuchi N; Horisaka K Eur J Pharmacol; 1990 Jun; 181(3):319-22. PubMed ID: 2200694 [TBL] [Abstract][Full Text] [Related]
5. Hyperglucagonemia induced in mice by tryptamine: involvement of the peripheral 5-HT2 receptors. Yamada J; Sugimoto Y; Kimura I; Watanabe Y; Takeuchi N; Horisaka K Eur J Pharmacol; 1992 Jun; 216(2):307-10. PubMed ID: 1397014 [TBL] [Abstract][Full Text] [Related]
6. Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery. Frenken M; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):484-92. PubMed ID: 3137478 [TBL] [Abstract][Full Text] [Related]
7. The evidence for the involvement of the 5-HT1A receptor in 5-HT syndrome induced in mice by tryptamine. Yamada J; Sugimoto Y; Horisaka K Jpn J Pharmacol; 1989 Nov; 51(3):421-4. PubMed ID: 2622095 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological analysis of the variation in behavioural responses to tryptamine in five strains of mice. Yamada J; Sugimoto Y; Horisaka K Eur J Pharmacol; 1987 Aug; 140(3):323-30. PubMed ID: 3653248 [TBL] [Abstract][Full Text] [Related]
9. The involvement of insulin in tryptamine-induced hypoglycemia in mice. Sugimoto Y; Kimura I; Yamada J; Watanabe Y; Takeuchi N; Horisaka K Life Sci; 1991; 48(17):1679-83. PubMed ID: 2016997 [TBL] [Abstract][Full Text] [Related]
10. Relationship between serotonin and tryptamine receptors in the rat stomach fundus. Cohen ML; Wittenauer LA J Pharmacol Exp Ther; 1985 Apr; 233(1):75-9. PubMed ID: 3981465 [TBL] [Abstract][Full Text] [Related]
11. Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors. Bradley PB; Humphrey PP; Williams RH Br J Pharmacol; 1985 Apr; 84(4):919-25. PubMed ID: 3159458 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle. Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657 [TBL] [Abstract][Full Text] [Related]
13. Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues. Leff P; Martin GR; Morse JM Br J Pharmacol; 1987 Jun; 91(2):321-31. PubMed ID: 3607360 [TBL] [Abstract][Full Text] [Related]
14. Hypothermia induced in mice by intracerebroventricular injection of tryptamine: involvement of the 5-HT1 receptor. Yamada J; Wakita H; Sugimoto Y; Horisaka K Eur J Pharmacol; 1987 Jul; 139(1):117-9. PubMed ID: 3653238 [TBL] [Abstract][Full Text] [Related]
15. Effects of tryptamine on plasma glucagon levels in mice. Yamada J; Sugimoto Y; Kimura I; Watanabe Y; Horisaka K Neurochem Res; 1994 Jan; 19(1):15-8. PubMed ID: 7908128 [TBL] [Abstract][Full Text] [Related]
16. Activation of peripheral serotonin2 receptors induces hypothermia in mice. Sugimoto Y; Yamada J; Horisaka K Life Sci; 1991; 48(5):419-23. PubMed ID: 1992284 [TBL] [Abstract][Full Text] [Related]
17. Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system. Cambridge D; Whiting MV; Butterfield LJ; Marston C Br J Pharmacol; 1995 Mar; 114(5):961-8. PubMed ID: 7780651 [TBL] [Abstract][Full Text] [Related]
18. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052 [TBL] [Abstract][Full Text] [Related]
19. Reduction in opioid and non-opioid forms of swim analgesia by 5-HT2 receptor antagonists. Kiefel JM; Paul D; Bodnar RJ Brain Res; 1989 Oct; 500(1-2):231-40. PubMed ID: 2605492 [TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. Jørgensen H; Knigge U; Warberg J Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]